Effect of bempedoic acid on new onset or worsening diabetes: a meta-analysis
When you restrict calories, your natural biology will resist weight loss to defend its set point
Demand for GLP-1 drugs also continues to outpace supply, raising questions about how much relief a single generic can bring
has received contract grant funding from Acadia Pharmaceuticals, Lundbeck, Takeda and Axovant pharmaceutical companies, as well as honoraria from Lundbeck, Lilly, Otsuka and Orion pharmaceutical companies
The combined appetite suppression may lead to insufficient caloric or nutritional intake, particularly in patients who are not overweight or who lose weight rapidly
Hims has drawn congressional letters and trade-press coverage over marketing practices